Pakistan's renowned nuclear scientist Dr Abdul Qadeer Khan passed away in Islamabad on Sunday morning. He was 85. Dr Abdul Qadeer was admitted at a local hospital where his health deteriorated early ...

Funeral prayers of nuclear scientist Dr. Abdul Qadeer Khan was offered at Faisal Mosque, Islamabad on Sunday. Dr Muhammad Al-Ghazali led the funeral prayer. Federal Ministers, parliamentarians, civil ...

While teclistamab looks on course to be the first BCMA-targeting bispecific antibody to reach the market, Pfizer is hot on J&J's heels with its BCMAxCD3 drug elranatamab and reported phase 2 data ...

Khaleda Rahman is Newsweek's National Correspondent based in London, UK. Her focus is reporting on abortion rights, race, education, sexual abuse and capital punishment. Khaleda joined Newsweek in ...

Billal Rahman is a Live News reporter based in London, U.K. He specializes in foreign affairs and U.S. politics. He joined Newsweek in 2024 from The Independent. He has covered the British Post ...

Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its oncology pipeline. New data from ...

The new double-headed antibody targets both CD3 and BCMA, a target that already features in approved therapies for myeloma, including GlaxoSmithKline's first-to-market antibody-drug conjugate (ADC ...